Search results: Found 9

Listing 1 - 9 of 9
Sort by
Pediatric Integrative Medicine: An Emerging Field of Pediatrics

ISBN: 9783038420620 9783038420637 Year: Pages: 172 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Added to DOAB on : 2015-10-22 07:30:21
License:

Loading...
Export citation

Choose an application

Abstract

Pediatric integrative medicine is a specialty that blends conventional medicine with evidence-based complementary therapies. Research shows that use of integrative medicine is common in children, especially in those living with chronic illness. Knowledge in several important areas of pediatric integrative medicine has expanded exponentially over the last decade. Despite this progress, many pediatricians and practitioners who work with children remain unaware of developments in this field.The goal of this special issue is to: define pediatric integrative medicine in its modern context, provide a history of the field’s evolution, highlight areas where research for its use in children is most robust at this time, and identify areas where research is lacking or evolving. Models of the use of integrative medicine in clinical pediatrics will be examined. Bioethics, informed consent, and provider credentialing will be discussed.Some of the most exciting clinical applications of integrative medicine in pediatrics include the use of mind-body medicine therapies such as guided imagery, hypnosis, and biofeedback for the treatment of pain. Mitigation of toxic stress and its health manifestations in children are another area of great potential application of the mind-body therapies. Other areas include integrative approaches to chronic illness, such as cancer, asthma, arthritis, bowel disease, and other chronic conditions where conventional therapies are necessary, yet leave treatment gaps that can be filled with evidence-based integrative therapies targeting lifestyle elements such as nutrition, sleep, physical activity, and social support that are often overlooked in this patient population. Integrative approaches have great potential in preventative heath. Conditions such as obesity and the metabolic syndrome affect a sobering number of children across all age ranges. Few successful treatment models exist for this patient population. Healthy lifestyle measures learned early in life can be a critical factor in providing a foundation for lifelong health for the child and family. Successful models for the use of integrative medicine in these patient populations are needed and will be explored.

Mechanics of Biomaterials

ISBN: 9783038421283 9783038421276 Year: Pages: 286 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Added to DOAB on : 2016-05-10 11:55:10
License:

Loading...
Export citation

Choose an application

Abstract

The mechanical behavior of biomedical materials and biological tissues are important for their proper function. This holds true, not only for biomaterials and tissues whose main function is structural such as skeletal tissues and their synthetic substitutes, but also for other tissues and biomaterials. Moreover, there is an intimate relationship between mechanics and biology at different spatial and temporal scales. It is therefore important to study the mechanical behavior of both synthetic and livingbiomaterials. This Special Issue aims to serve as a forum for communicating the latest findings and trends in the study of the mechanical behavior of biomedical materials.

Magnetic Resonance Sensors

ISBN: 9783906980980 9783906980997 Year: Pages: 224 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Added to DOAB on : 2015-10-22 09:04:48
License:

Loading...
Export citation

Choose an application

Abstract

Magnetic Resonance finds applications, from spectroscopy to imaging, on a routine basis in the majority of research and medical institutions. It is also becoming more frequently used for specific applications in which the whole instrument and system is designed for optimum operation. Magnetic Resonance sensors have been applied to fields as varied as petro-chemistry - with borehole logging, food engineering - with online process monitoring, emergency medicine - with point of care diagnostics and civil engineering - with sensors for monitoring cement drying. This great diversity is seeing exciting developments in magnetic resonance sensing technology published in application specific journals where they are often not seen by the wider sensor community.

Advances and New Perspectives in Marine Biotechnology

Authors: --- ---
ISBN: 9783038421061 9783038421092 Year: Volume: Volume 1 Pages: 428 DOI: 10.3390/books978-3-03842-109-2 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Biotechnology
Added to DOAB on : 2015-10-22 10:01:02
License:

Loading...
Export citation

Choose an application

Abstract

As the Century of Biology begins to bear fruit, through the translation of predictive biological understanding into applications that enhance the human condition and maintain biodiversity, the almost infinite potential of marine biological resources will be unlocked. Although Marine Biotechnology already has delivered products for medicine, food, bioenergy, nanomaterials, and bioremediation, less than 5% of our vast oceanic environment has been explored. Marine Biotechnology is a scientifically and economically expanding enterprise that is poised to harness the enormous but uncharted functional diversity of marine life, with its novel and rich array of biodesigns and biosynthetic capabilities. From this pursuit comes new genes, chemicals, materials, and inspirations for the benefit of industry, nutrition, and medicine, and which enable the sustainable use and management of the world’s oceans. This Special Issue in Marine Drugs highlights the cutting-edge developments in Marine Biotechnology with a collection of papers written by authors who are leading experts in the field, including selected papers from the 10th International Marine Biotechnology Conference (IMBC-2013), the premier meeting in marine biotechnology, which is held under the auspices of the International Marine Biotechnology Association.

Advances and New Perspectives in Marine Biotechnology

Authors: --- ---
ISBN: 9783038421078 9783038421108 Year: Volume: Volume 2 Pages: 654 DOI: 10.3390/books978-3-03842-110-8 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Biotechnology
Added to DOAB on : 2015-10-22 10:04:44
License:

Loading...
Export citation

Choose an application

Abstract

As the Century of Biology begins to bear fruit, through the translation of predictive biological understanding into applications that enhance the human condition and maintain biodiversity, the almost infinite potential of marine biological resources will be unlocked. Although Marine Biotechnology already has delivered products for medicine, food, bioenergy, nanomaterials, and bioremediation, less than 5% of our vast oceanic environment has been explored. Marine Biotechnology is a scientifically and economically expanding enterprise that is poised to harness the enormous but uncharted functional diversity of marine life, with its novel and rich array of biodesigns and biosynthetic capabilities. From this pursuit comes new genes, chemicals, materials, and inspirations for the benefit of industry, nutrition, and medicine, and which enable the sustainable use and management of the world’s oceans. This Special Issue in Marine Drugs highlights the cutting-edge developments in Marine Biotechnology with a collection of papers written by authors who are leading experts in the field, including selected papers from the 10th International Marine Biotechnology Conference (IMBC-2013), the premier meeting in marine biotechnology, which is held under the auspices of the International Marine Biotechnology Association.

Beyond Techno-Utopia: Critical Approaches to Digital Health Technologies

Author:
ISBN: 9783038420606 9783038420613 Year: Pages: 168 DOI: 10.3390/books978-3-03842-061-3 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Added to DOAB on : 2015-10-22 09:00:15
License:

Loading...
Export citation

Choose an application

Abstract

The title for this special issue was devised as a direct challenge to the prevailing solutionist and instrumental approaches to the application of digital technologies to medicine and public health. In formulating the idea and title for the special issue, I wanted to inspire some provocative and challenging commentary and research on what I interpreted as a dominantly techno-utopian position on digital health. One important approach that I particularly wanted to encourage, and which I articulate in my own contribution to the special issue, is that which views digital health technologies as social, cultural and material artefacts which have political implications and embodied entanglements with humans and other nonhuman actors.- Deborah Lupton, Guest Editor

Radiopharmaceutical Chemistry between Imaging and Endoradiotherapy

ISBN: 9783038420842 9783038420859 Year: Pages: 256 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Added to DOAB on : 2015-10-22 09:15:21
License:

Loading...
Export citation

Choose an application

Abstract

Positron emission tomography (PET), single photon emission computed tomography (SPECT), and the combined imaging modalities realised in the en-vogue hybrid technologies PET/CT and PET/MR represent the state-of-the-art diagnostic imaging technologies in nuclear medicine which are used for the highly sensitive non-invasive imaging of biological processes at the subcellular and molecular level in a respective patient for the visualisation of rather early disease states or for early inspection of treatment response after chemotherapy, radiation- or radioendotherapy.Radiolabelled molecules, bearing a “radioactive lantern”, function as so called Radiopharmaceuticals which have to be compliant with the pharmaceuticals act, and can be termed as “food” of nuclear medicine. In general, the specialised field Radiopharmaceutical Chemistry focusses on the development, synthesis and radiolabelling of aforementioned “food”, such as small molecules, biotechnology-derived antibodies or (cyclised) (oligo)peptides which are used to address clinically relevant biological “downstream” targets such as receptors, enzymes, transport systems and others. Addressing “upstream” targets such as DNA- and RNA-fragments using corresponding radioactive substrates represents a further feasible strategy.Originally, Radiopharmaceutical Chemistry descends from radiochemistry and radiopharmacy as well as nuclear chemistry and uses methods finally aiming at the production of radioactive substances for human application which are essential for non-invasive in vivo imaging by means of the aforementioned scintigraphic methods PET or SPECT.The cornerstone for applicable radiochemistry in nuclear medicine was set by the Hungarian chemist George Charles de Hevesy who received the Nobel Prize in 1943 for his work on the radioindicator principle. This principle is based on the idea that the absolute amount of the administered substance is below the dose needed to induce a pharmacodynamic effect. Nowadays, a radioactive substance that can be traced in vivo as it moves through the living organism is termed radiotracer or radiopharmaceutical. As mentioned above, the biodistribution of radiopharmaceuticals is measured non-invasively reflecting functional or molecular disorders without pharmacologically affecting the organism.In the era of personalised medicine the diagnostic potential of radiopharmaceuticals is directly linked to a subsequent individual therapeutic approach called radioendotherapy. Depending on the “radioactive lantern” (gamma or particle emitter) used for radiolabelling of the respective tracer molecule, the field Radiopharmaceutical Chemistry can contribute to the set-up of an in vivo “theranostic” approach especially in tumour patients by offering tailor-made (radio)chemical entities labelled either with a diagnostic or a therapeutic radionuclide.To succeed in the design of targeted high-affinity radiopharmaceuticals that can measure the alteration of receptors serving at the same time as biological targets for individualised radioendotherapy several aspects need to be considered: (i) reasonable pharmacological behaviour (especially pharmacokinetics adjusted to the physical half-life of the used radionuclide), (ii) ability to penetrate and cross biological membranes, (iii) usage of chemical as well as biological amplification strategies (e.g. pretargeting, biological trapping of converted ligands, change of the physicochemical behaviour of the radiopharmaceutical after target interaction, combination with biotransporters and heterodimer approaches), (iv) availability of radiopharmaceuticals with high specific activities and in vivo stability.

Keywords

Antimicrobial Peptides

Author:
ISBN: 9783038420729 9783038420736 Year: Pages: 336 DOI: 10.3390/books978-3-03842-073-6 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Added to DOAB on : 2015-10-22 10:29:38
License:

Loading...
Export citation

Choose an application

Abstract

Antimicrobial peptides (AMPs) are gene-encoded, ancient (and important) mediators of innate host defense that exert direct or indirect antimicrobial action as well as possessing other important biologic activities (e.g., neutralization of endotoxin and anti-biofilm action) that help to protect vertebrates, invertebrates and plants from invading pathogens. While the emergence of multi-antibiotic resistant pathogens (and the desperate need to develop new anti-infectives) has been a recent force driving the field, interest in AMPs has an earlier origin in studies of how phagocytes kill bacteria by oxygen-independent processes. AMPs responsible for such killing of microbes by rabbit and human neutrophils were later purified by Ganz, Selsted and Lehrer, which they termed defensins; at the time of this writing, literally thousands of defensin-based publications can be found in the scientific literature! The initial reports on defensins and the earlier report by Boman’s group on the purification and action of an insect AMP represented a historical and defining point for the AMP field as they, in hindsight, demanded the recognition of AMP research as a unique discipline that has important linkages to other important fields of medicine, especially those of microbiology, infectious diseases and immunology. On a personal note, I remember conferences on phagocytes and host defense in the early 1980s where the topic of AMPs was relegated to one short session in a five day period! Now, we have hundreds of international “AMPologists” with expertise in chemistry, biochemistry, molecular and structural biology, cell biology, microbiology, pharmacology, or medicine who have built their research careers around AMPs and can now attend international conferences dedicated to advances in AMP research.

iPS Cells for Modelling and Treatment of Human Diseases

ISBN: 9783038421221 9783038421214 Year: Pages: 422 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Medicine (General)
Added to DOAB on : 2016-05-09 15:30:07
License:

Loading...
Export citation

Choose an application

Abstract

The field of reprogramming somatic cells into induced pluripotent stem cells (iPSC) has moved very quickly, from bench to bedside in just eight years since its first discovery. The best example of this is the RIKEN clinical trial this year in Japan, which will use iPSC derived retinal pigmented epithelial (RPE) cells to treat macular degeneration (MD). This is the first human disease to be tested for regeneration and repair by iPSC-derived cells and others will follow in the near future. Currently, there is an intense worldwide research effort to bring stem cell technology to the clinic for application to treat human diseases and pathologies. Human tissue diseases (including those of the lung, heart, brain, spinal cord, and muscles) drive organ bioengineering to the forefront of technology concerning cell replacement therapy. Given the critical mass of research and translational work being performed, iPSCs may very well be the cell type of choice for regenerative medicine in the future. Also, basic science questions, such as efficient differentiation protocols to the correct cell type for regenerating human tissues, the immune response of iPSC replacement therapy and genetic stability of iPSC-derived cells, are currently being investigated for future clinical applications.

Listing 1 - 9 of 9
Sort by
Narrow your search

Publisher

MDPI - Multidisciplinary Digital Publishing Institute (9)


License

CC by (5)

CC by-nc-nd (4)


Language

english (9)


Year
From To Submit

2015 (9)